‘We’ve come a long way’: Recent Sjögren’s research provides ‘more hope than ever before’
Research into Sjögren’s disease — both analyzing the condition itself and testing potential treatments — has come a long way in the past decade.“Fifteen years ago, we had no clinical trials, no pharma interest in Sjögren’s, and we were starting to see lupus trials fail one after the other,” Kathy M. Hammitt, vice president of medical and scientific affairs at